Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan

J Infect Chemother. 2018 Aug;24(8):641-647. doi: 10.1016/j.jiac.2018.03.015.

Abstract

We conducted a nationwide molecular epidemiological study of Clostridium difficile infection (CDI) in Japan investigated the correlation between the presence of binary toxin genes and CDI severity. This is the first report on molecular epidemiological analyses for CDI in multiple university hospitals in Japan, to our knowledge. We examined 124,484 hospitalized patients in 25 national and public university hospitals in Japan between December 2013 and March 2014, investigating antimicrobial susceptibilities and toxin-related genes for C. difficile isolates from stools. Epidemiological genetic typing was performed by PCR-ribotyping and repetitive sequence-based (rep)-PCR to examine the genetic similarities. The results detected toxin A-positive, toxin B-positive, binary toxin-negative (A+B+CDT-) detected from 135 isolates (80.8%) and toxin A-negative, toxin B-positive, binary toxin-negative (A- B+CDT-) in 23 (13.8%). Toxin A-positive, toxin B-positive, and binary toxin-positive (A+B+CDT+) were seen in 9 isolates (5.4%). Vancomycin (n = 81, 37.7%) or metronidazole (n = 88, 40.9%) therapies were undertaken in analyzed cases. Ribotypes detected from isolates were 017/subgroup 1, 070, 078, 126, 176, 449, 475/subgroup 1, 499, 451, 566 and newtypes. Rep-PCR classified 167 isolates into 28 cluster groups including 2-15 isolates. In addition, 2 pairs of strains isolated from different institutions belonged to the same clusters. Seven out of 9 (77.8%) of the patients with binary toxin producing strains had "mild to moderate" outcome in evaluated symptoms. In conclusion, we found that binary toxin did not show regional specificity and had no relevance to severity of CDI.

Keywords: Clostridium difficile infection; Clostridium difficile toxin; Cluster analysis; Epidemiology; Nationwide study.

Publication types

  • Multicenter Study

MeSH terms

  • ADP Ribose Transferases / genetics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Proteins / genetics
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / genetics*
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / drug therapy
  • Clostridium Infections / epidemiology*
  • Clostridium Infections / microbiology
  • Epidemiological Monitoring
  • Feces / microbiology
  • Female
  • Hospitals, University / statistics & numerical data*
  • Humans
  • Inhibitory Concentration 50
  • Japan / epidemiology
  • Male
  • Metronidazole / therapeutic use
  • Microbial Sensitivity Tests
  • Middle Aged
  • Molecular Epidemiology
  • Polymerase Chain Reaction
  • Ribotyping / methods
  • Severity of Illness Index
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Metronidazole
  • Vancomycin
  • ADP Ribose Transferases
  • actin-specific ADP-ribosyltransferase, Clostridium